Species specificity of recognition by the alternative pathway of complement
- PMID: 3155536
Species specificity of recognition by the alternative pathway of complement
Abstract
The recognition function of the alternative complement pathway was studied with isolated human and rabbit components. Zymosan and homologous and heterologous erythrocytes were used as representative activators or nonactivators. The binding affinity of Factor B and Factor H for particle-bound C3b was measured. In both species, the average affinity of Factor H for bound C3b on homologous cells (nonactivators) was eight to 10 times higher than on zymosan particles (activators). The interaction between Factor H and C3b on rabbit erythrocytes was species-specific: rabbit Factor H bound strongly to rabbit C3b on rabbit erythrocytes and also on human erythrocytes, which are nonactivators for the rabbit alternative pathway. Human Factor H bound strongly to human C3b on human erythrocytes but seven times weaker on rabbit erythrocytes, which are activators of the human alternative pathway. No substantial differences were found in the binding of Factor B to bound C3b regardless of the nature of the particle to which C3b was bound. The results indicate that in the two species studied, the molecular mechanism of recognition is analogous and that recognition is species-specific.
Similar articles
-
The alternative pathway of complement.Springer Semin Immunopathol. 1984;7(2-3):163-92. doi: 10.1007/BF01893019. Springer Semin Immunopathol. 1984. PMID: 6238433 Review. No abstract available.
-
Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.Proc Natl Acad Sci U S A. 1990 May;87(10):3982-6. doi: 10.1073/pnas.87.10.3982. Proc Natl Acad Sci U S A. 1990. PMID: 1692629 Free PMC article.
-
Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces.Eur J Immunol. 1989 Nov;19(11):2145-50. doi: 10.1002/eji.1830191126. Eur J Immunol. 1989. PMID: 2480904
-
Phagocytosis by human monocytes of particles activating the alternative pathway of complement.Scand J Immunol. 1984 Jan;19(1):31-9. doi: 10.1111/j.1365-3083.1984.tb00897.x. Scand J Immunol. 1984. PMID: 6701471
-
Activation of the alternative complement pathway.CRC Crit Rev Immunol. 1979 Nov;1(1):1-32. CRC Crit Rev Immunol. 1979. PMID: 162484 Review. No abstract available.
Cited by
-
The alternative pathway of complement.Springer Semin Immunopathol. 1984;7(2-3):163-92. doi: 10.1007/BF01893019. Springer Semin Immunopathol. 1984. PMID: 6238433 Review. No abstract available.
-
Disruption of the alternative pathway convertase occurs at the staphylococcal surface via the acquisition of factor H by Staphylococcus aureus.Mol Immunol. 2011 Jan;48(4):683-90. doi: 10.1016/j.molimm.2010.11.014. Epub 2010 Dec 15. Mol Immunol. 2011. PMID: 21163532 Free PMC article.
-
Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.Proc Natl Acad Sci U S A. 1990 May;87(10):3982-6. doi: 10.1073/pnas.87.10.3982. Proc Natl Acad Sci U S A. 1990. PMID: 1692629 Free PMC article.
-
Activation of the complement system by pathogenic fungi.Clin Microbiol Rev. 1996 Jan;9(1):34-46. doi: 10.1128/CMR.9.1.34. Clin Microbiol Rev. 1996. PMID: 8665475 Free PMC article. Review.
-
Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation.Infect Immun. 1992 Mar;60(3):721-7. doi: 10.1128/iai.60.3.721-727.1992. Infect Immun. 1992. PMID: 1541544 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Miscellaneous